| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07116837 Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-12 | NCT07116837 Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults |
Enrollment reduced: 3500 -> 3113 participants |
| 2026-06-12 | NCT07116837 Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults |
date change Primary completion moved earlier: 2026-07-18 -> 2026-06-14 |
| 2026-06-12 | NCT07116837 Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults |
date change Completion moved earlier: 2026-07-18 -> 2026-06-14 |
| 2026-05-29 | NCT07428330 Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in… |
date change Completion pushed: 2027-09 -> 2028-03 |
| 2026-05-23 | NCT07428330 Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in… |
Enrollment increased: 2912 -> 7597 participants |
| 2026-05-21 | NCT06411756 Physical Activity Centers Empowerment |
Trial completed |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07639242 Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07634653 Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic… | Not Yet Recruiting | |
| 2026-06-05 | NCT07630168 Effects of Infusion Timing on Treatment Response in Solid Tumors | Phase 2 | Not Yet Recruiting |
| 2026-06-03 | NCT07624123 Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in… | Not Yet Recruiting | |
| 2026-05-26 | NCT07605949 Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML | Phase 2 | Not Yet Recruiting |
| 2026-05-20 | NCT07599462 Pilot Study of Communication for Dual Users of Cigarettes and E-cigarettes | Recruiting | |
| 2026-05-15 | NCT07588607 Social Media Posts About Cancer: Five Timepoints | Completed |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting |
| NCT07278557 | Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia | Head and Neck Cancer | Recruiting |
| NCT05578326 | Study of Trilaciclib and Lurbinectidin | Lung Cancer | Recruiting |
| NCT06902311 | Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous… | Breast Cancer | Recruiting |
| NCT07069595 | PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease | Breast Cancer | Recruiting |
| NCT07276880 | Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion… | Breast Cancer | Recruiting |
| NCT06727773 | Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of… | Breast Cancer | Recruiting |
| NCT07340541 | Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies | Breast Cancer | Recruiting |
| NCT05472792 | Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation… | Breast Cancer | Recruiting |
| NCT05145400 | Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma | Multiple Myeloma | Recruiting |
| NCT07225114 | Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging | Breast Cancer | Recruiting |
| NCT05366166 | Pembrolizumab Plus Olaparib in LA-HNSCC | Squamous Cell Carcinoma of Head and Neck | Active, Not Recruiting |
| NCT03174275 | Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and… | Carcinoma, Squamous Cell | Active, Not Recruiting |
| NCT07484139 | H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in… | Oral Cavity Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT07545746 | Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in… | HIV Infections | Not Yet Recruiting |
| NCT07078838 | Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1… | Endometrial Cancer | Not Yet Recruiting |
| NCT07630168 | Effects of Infusion Timing on Treatment Response in Solid Tumors | Lung Cancer | Not Yet Recruiting |
| NCT07526597 | Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK… | Chronic Lymphocytic Leukemia | Not Yet Recruiting |
| NCT05911321 | Isa-Pom-Dex in Elderly/Frail Subjects With RRMM | Multiple Myeloma | Active, Not Recruiting |
| NCT07605949 | Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML | Leukemia Acute Myeloid | Not Yet Recruiting |
| NCT04548648 | A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas | Central Nervous System Lymphoma | Active, Not Recruiting |
| NCT07639242 | Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or… | Lung Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06096038 | Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC | Head and Neck Cancer | Recruiting |
| NCT06483555 | Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel | Pancreatic Adenocarcinoma | Recruiting |
| NCT04700527 | The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized… | Toxicity | Recruiting |